Thermo Fisher Completes $2.53 Billion Common Stock Offering

Thermo Fisher Completes $2.53 Billion Common Stock Offering

Attorney News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
Our team provides guidance on all facets of swaps, futures and derivatives market activity, including regulatory compliance, transactions, litigation, and investigations and enforcement.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.

A team of WilmerHale transactional lawyers represented Thermo Fisher Scientific Inc. in its recently completed $2.53 billion underwritten public offering of its common stock made in connection with the forward sale agreements described below. J.P. Morgan and Barclays acted as joint book-running managers and as representatives of the underwriters for the offering. BofA Merrill Lynch acted as book-running manager for the offering. Thermo Fisher intends to use the proceeds from the settlement of the forward sale agreements to fund a portion of its recent acquisition of Life Technologies Corporation.

The forward sale agreements, entered into with affiliates and forward counterparties of J.P. Morgan and Barclays borrowed stock from third parties for sale in the offering. This enabled Thermo Fisher to raise equity based on its current stock price, but delay dilution of current stock owners' holdings and earnings per share until they settle the forward sale agreements.

To learn more about the deal, read Thermo Fisher’s press release.

The WilmerHale team representing Thermo Fisher includes Partners David Redlick and Erika Robinson; Senior Associates Todd Anderman and Jared DeMatteis; Associates Jordan Schwartz and Kevin Bale, with Partner Julie Hogan Rodgers on tax matters. The derivatives team included Partners Jeannette Boot and Dino Wu; and Associate Ellie Guadiana.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel